Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies
Article in ACR Open Rheumatology (March 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in ACR Open Rheumatology (March 2023)
Article in Therapeutic Advances in Musculoskeletal Disease (January 2021)
Article in Dermatologica Sinica (January 2021)